We evaluate the results and complications of renal transplantation in HbsAg or HCV positive patients retrospectively. Results: A total of 42 patients have HbsAg positive and 11 patients have HCV positive. In HbsAg positive patients, chronic rejection in 9 cases (21.4%)+ malignant lymphoma of liver in one case (2.3%) liver cirrhosis in 2 cases (4.7%)chronic active hepatitis in one case (2.3%) hepatic encephalopathy in one case (2.3%) mortality rate in 7 cases (16%) were occurred. The one+ five and ten years graft and patient survival rates were 85.3%+ 68.2% - 58.5% and 95.1%+ 87.8% + 87.8% respectively. In HCV positive patients, chronic rejection in 5 cases (45.4%)and hepatitis in one case (9%) were occurred. The one and five-year graft and patient survival rates were 87.5% + 62.5% and 100% respectively. In HbsAg negative and HCV negative patients, the one five and ten years graft and patient survival rates were 87.2%, 66.2%, 49.8% and 92.8%+ 83.7% + 73.3% respectively. Conclusion: HbsAg positive or HCV positive recipients could undergo renal transplantation with comparable results to other patients.